*Capacity depends on access to sufficient supplies and equipment as well as positivity rates. Turnaround time refers to the average expected number of days required to collect, transport, perform testing on and report results for a specimen.

The findings, based on de-identified laboratory data from 799,496 patients, suggest that many individuals failed to receive preventive or other forms of medical care, such as routine screenings, during the pandemic, raising the prospect of a future wave of cancers diagnosed at more advanced stages of disease. In other news, a Quest Diagnostics Health Trends® study published today in JAMA Network Open reveals that new diagnoses of eight common types of cancer (prostate, breast, colorectal, lung, pancreatic, cervical, gastric and esophageal) significantly declined during most of the first year of the pandemic (March 2020-March 2021). To enhance preparedness, we are adding COVID-19 testing platforms in laboratories in regions where demand is comparatively high.

Despite the nationwide COVID-19 surge, we are able to perform and report the majority of COVID-19 tests within 1 day*. We have performed and reported over 54 million COVID-19 molecular diagnostic and antibody serology tests since we began to provide these services in 2020. Quest Maintains 1-Day Turnaround Time for COVID-19 Diagnostic Testing, Reports New Research in JAMA Network Open, Oncology Revealing Rate of Cancer Diagnosis Declined Significantly During the Pandemic

To receive these media updates, please email Please check back to this page periodically for the latest information.

Hep a igg quest diagnostics